Jim Simons Foghorn Therapeutics Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q3 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 118,236 shares of FHTX stock, worth $554,526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,236
Previous 62,636
88.77%
Holding current value
$554,526
Previous $294,000
96.6%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FHTX
# of Institutions
88Shares Held
37MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$59.4 Million22.92% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$24.9 Million1.4% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$15.3 Million0.3% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.46MShares$11.5 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$10.8 Million0.01% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $195M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...